JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (3)
2018
-
De novo lipogenesis represents a therapeutic target in mutant Kras non-small cell lung cancer
FASEB Journal, Vol. 32, Núm. 12, pp. 7018-7027
2013
-
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1 -mutant lung cancer
Cancer Discovery, Vol. 3, Núm. 8, pp. 870-879
2009
-
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
Journal of Clinical Investigation, Vol. 119, Núm. 8, pp. 2160-2170